Single vs. combination immunotherapeutic strategies for glioma

INTRODUCTION: Malignant gliomas are highly invasive tumors, associated with a dismal survival rate despite standard of care, which includes surgical resection, radiotherapy and chemotherapy with temozolomide (TMZ). Precision immunotherapies or combinations of immunotherapies that target unique tumor...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Expert Opin Biol Ther
Egile Nagusiak: Chandran, Mayuri, Candolfi, Marianela, Shah, Diana, Mineharu, Yohei, Yadav, Vivek, Koschmann, Carl, Asad, Antonela S., Lowenstein, Pedro R., Castro, Maria G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5451096/
https://ncbi.nlm.nih.gov/pubmed/28286975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2017.1305353
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak